Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 3401
Selected: 0
NCT IDTitle
NCT05143996CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
NCT02669862A Study of A-101 Solution in Subjects With Common Warts.
NCT01804842Assessing the Effect of Met DR on Plasma Glucose and PK in Subjects With T2DM
NCT00785356Safety and Efficacy of Proellex in Pre-Menopausal Anemic Women With Symptomatic Uterine Fibroids
NCT02605122Safety and Efficacy of Solithromycin in Adolescents and Children With Community-Acquired Bacterial Pneumonia
NCT06663137Open Label Study to Evaluate the Safety and Efficacy of NDV01 KIT in High Grade NMIBC
NCT06622070A Study of SPY002-072 in Healthy Volunteers
NCT05113745A Study to Assess the Long-term Efficacy and Safety of AXS-12 (Reboxetine) in Subjects With Narcolepsy (ENCORE)
NCT03815695A SAD/MAD to Assess the Safety, PK/PD of FT-4202 in Healthy Volunteers and Sickle Cell Disease Patients
NCT04128423Study of AMV564 in Subjects With Advanced Solid Tumors
NCT02239731Safety, Tolerability and Efficacy Study of Doxycycline Foam for the Prevention of EGFRI Skin Toxicity in Cancer Patients
NCT00874302Safety and Efficacy of 25 and 50 mg Doses of Proellex® in Treating the Recurrence of Uterine Fibroid Symptoms
NCT04754802PH94B Nasal Spray for Anxiety Induced by a Public Speaking Challenge
NCT03343639Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Plaque Psoriasis
NCT03910660A Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype.
NCT01723020A Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma
NCT03373877Evaluation of Ruxolitinib in Combination With PU-H71 for Treatment of Myelofibrosis
NCT01765179Safety and Efficacy Trial of Testosterone Undecanoate
NCT06628362A Study of Enicepatide (CT-388) in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus
NCT06597656A Gene Transfer Therapy to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) Following Therapeutic Plasma Exchange (Plasmapheresis) in Participants With Duchenne Muscular Dystrophy (DMD) and Pre-existing Antibodies to AAVrh74
NCT01762839A Study to Assess the Cardiac Safety of Oritavancin in Healthy Participants
NCT06923527Circulating Tumor DNA
NCT06736262A Phase 2, Open-Label, Extension Study to Evaluate Long Term Safety and Clinical Activity of Briquilimab in Participants From Jasper-Sponsored Chronic Urticaria Trials
NCT06882031Evaluate the Pharmacokinetics of Oral Arsenic Trioxide Solution Under Fasting and Fed Conditions, to Compare Intravenous Arsenic Trioxide, in Acute Promyelocytic Leukemia
NCT02318602Cannabidiol Oral Solution as an Adjunctive Treatment for Treatment-resistant Seizure Disorder
NCT05890872Aliya™ Pulsed Electric Fields (PEF) for Advanced Cancer
NCT06969170Safety, Tolerability, and Preliminary Efficacy of Psilocybin Oral Solution in Adults With Generalized Anxiety Disorder
NCT00231569Dose-escalating Safety Study in Subjects on Stable Statin Therapy
NCT04659122A Clinical Safety Study on AT-100 in Treating Adults With Severe COVID-19 Infection or Severed Community Acquired Pneumonia
NCT03538951Study to Evaluate the Efficacy, Safety, and Tolerability of Topical VDA-1102 Ointment in Subjects With Actinic Keratosis
NCT04677829Safety and Tolerability of PNT001 in Patients With Acute Traumatic Brain Injury (TBI)
NCT00777231Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies
NCT06875310A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
NCT01764386Method-of-Use Study Assessing the Effect of Naltrexone Sustained Release (SR)/ Bupropion SR on Body Weight and Cardiovascular Risk Factors in Overweight and Obese Subjects
NCT07563829NPX372, a B7-H7:CD3 Bispecific Antibody, in Selected Solid Tumor Malignancies
NCT02015637Comparison of Delafloxacin Versus Ceftriaxone for the Treatment of Uncomplicated Gonorrhea
NCT04184050Study of HPN217 in Participants With Relapsed/Refractory Multiple Myeloma MK-4002 (MK-4002-001)
NCT05005338A Study to Determine the Absolute Bioavailability of BIIB122/DNL151 in Healthy Subjects
NCT07210515Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)
NCT02478450Study to Investigate the Safety of the Transplantation (by Injection) of Human Glial Restricted Progenitor Cells (hGRPs; Q-Cells®) Into Subjects With Amyotrophic Lateral Sclerosis (ALS)
NCT00662116Beginning a Randomized Evaluation of the AGE Breaker Alagebrium in Diastolic Heart Failure (BREAK-DHF-I)
NCT06788639A Study of Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Treated With Lisocabtagene Maraleucel in the Post-Marketing Setting
NCT03256552Study to Assess the Efficacy and Safety of Three Doses of PT001 in Japanese Subjects With Moderate to Severe COPD
NCT00640926Safety and Efficacy Study of Oxazolidinone to Treat Pneumonia
NCT05103878A Phase 1, Single-Ascending-Dose Study of BT051 in Healthy Subjects
NCT02137525Study to Explore Effectiveness of Sublingual Fentanyl Spray in Emergency Department Patients With Acute Pain
NCT02286817Phase I Single Dose, Open-Label Pharmacokinetic Study and Single-Blind, Placebo-Controlled Dose Escalation Study of NFC-1 in Adolescents With Attention-Deficit Hyperactivity Disorder
NCT05285540Study to Evaluate DT-216 in Adult Patients With Friedreich Ataxia
NCT03194555The Preventive Treatment of Migraine With Low-Dose Naltrexone and Acetaminophen Combination
NCT00004408Phase III Randomized Study of Poloxamer 188 for Vaso-Occlusive Crisis of Sickle Cell Disease